CD40-Activated Macrophages Become Highly Susceptible to X4 Strains of Human Immunodeficiency Virus Type 1
- 20 January 2002
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 18 (2) , 103-113
- https://doi.org/10.1089/08892220252779647
Abstract
Activating cells of the immune system may stimulate human immunodeficiency virus type 1 (HIV-1) replication and contribute to select pathogenic variants in vivo. Here, we examined the possible effect of a major pathway of immune activation, CD40 interaction with its ligand (CD40L), on the susceptibility of monocyte-derived macrophages (MDMs) to various HIV-1 strains. Stimulation of MDMs with CD40L led to reduced replication of R5 HIV-1(Ba-L), whereas this strongly enhanced the replication of X4 HIV-1(Lai) as well as of X4 primary isolates, and this was associated with strong cytopathic effects. The replication of X4 strains was inhibited by stromal cell-derived factor 1, an indication of the restricted usage of CXCR4 as virus coreceptor in this case. CD40L induced the activation of mitogen-activated protein kinases ERK1/ERK2 and stimulated MDMs to secrete RANTES (regulated on activation, normal T cell expressed and secreted), macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, interleukin 6 (IL-6), IL-1beta, and tumor necrosis factor alpha. From this data, it may be hypothesized that activated macrophages represent a favorable environment for the replication of classically T lymphocyte-tropic X4 variants and, thus, may contribute significantly to the selection of such variants at late stages of clinical HIV-1 infection.Keywords
This publication has 59 references indexed in Scilit:
- SOLUBLE CD40 LIGAND INDUCES β-CHEMOKINE PRODUCTION BY MACROPHAGES AND RESISTANCE TO HIV-1 ENTRYCytokine, 2000
- Tumor necrosis factor-? stimulates prostaglandin F2? secretion by bovine luteal cells via activation of mitogen-activated protein kinase and phospholipase A2 pathwaysMolecular Reproduction and Development, 2000
- Laureate ESCI award for excellence in clinical science 1999 Cytokines and the human immunodeficiency virus: from bench to bedsideEuropean Journal of Clinical Investigation, 1999
- Cofactors for Human Immunodeficiency Virus Entry into Primary MacrophagesThe Journal of Infectious Diseases, 1999
- The Inhibitory Effect of RANTES on the Infection of Primary Macrophages by R5 Human Immunodeficiency Virus Type-1 Depends on the Macrophage Activation StateVirology, 1998
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Dendritic Cells Enhance Growth and Differentiation of CD40-activated B LymphocytesThe Journal of Experimental Medicine, 1997
- IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39Annual Review of Immunology, 1996
- Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.The Journal of Experimental Medicine, 1990
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985